Search Knowledge Base

14 results for "hypolipidemic-agents"

Impact of conventional lipid-lowering therapy on circulating levels of proprotein convertase subtilisin/kexin type 9: A systematic review and meta-analysis of randomised controlled trials pubmed_article
Evidence Source 2026 PMID: 41656962
Effect of lipid-lowering therapies on lipoprotein(a) levels: a comprehensive meta-analysis of randomized controlled trials pubmed_article
Evidence Source 2025 PMID: 40618457
Alliaceae versus Brassicaceae for Dyslipidemia: State of the Art and Future Perspectives. Systematic Review and Meta-Analysis of Clinical Studies pubmed_article
Evidence Source 2024 PMID: 39343737
Targeting dyslipidemia by herbal medicines: A systematic review of meta-analyses pubmed_article
Evidence Source 2021 PMID: 34252530
Association of lowering apolipoprotein B with cardiovascular outcomes across various lipid-lowering therapies: Systematic review and meta-analysis of trials pubmed_article
Evidence Source 2020 PMID: 31475865
[Systematic review and Meta-analysis on efficacy and safety of berberine for dyslipidemia] pubmed_article
Evidence Source 2020 PMID: 32237527
Effect of Resveratrol on Blood Lipid Levels in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis pubmed_article
Evidence Source 2019 PMID: 30569644
Effects of quercetin supplementation on lipid profile: A systematic review and meta-analysis of randomized controlled trials pubmed_article
Evidence Source 2017 PMID: 25897620
Role of Niacin in Current Clinical Practice: A Systematic Review pubmed_article
Evidence Source 2017 PMID: 27793642
Triglyceride-lowering therapies reduce cardiovascular disease event risk in subjects with hypertriglyceridemia pubmed_article
Evidence Source 2016 PMID: 27578122
Effect of extended-release niacin on plasma lipoprotein(a) levels: A systematic review and meta-analysis of randomized placebo-controlled trials pubmed_article
Evidence Source 2016 PMID: 27733255
The current state of niacin in cardiovascular disease prevention: a systematic review and meta-regression pubmed_article
Evidence Source 2013 PMID: 23265337
Effect of niacin therapy on cardiovascular outcomes in patients with coronary artery disease pubmed_article
Evidence Source 2010 PMID: 20208032
[Evaluation of acquired data on long-term risk of hypolipidemic treatments] pubmed_article
Evidence Source 1992 PMID: 1285692

Evidence Search Results semantic · quality-ranked

Impact of conventional lipid-lowering therapy on circulating levels of proprotein convertase subtilisin/kexin type 9: A systematic review and meta-analysis of randomised controlled trials meta_analysis pubmed_article
Quality: 64 2026 PMID: 41656962 DOI: 10.1111/dom.70475
Antiplatelet agents and anticoagulants for hypertension systematic_review pubmed_article
Quality: 76 2022 PMID: 35900898 DOI: 10.1002/14651858.CD003186.pub4
Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients meta_analysis pubmed_article
Quality: 80 2014 PMID: 25038074 DOI: 10.1136/bmj.g4379
Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis systematic_review pubmed_article
Quality: 69 2013 PMID: 23728635 DOI: 10.1002/14651858.CD000951.pub2
Lipid-lowering agents for nephrotic syndrome meta_analysis pubmed_article
Quality: 69 2013 PMID: 24327265 DOI: 10.1002/14651858.CD005425.pub2
Amphotericin B lipid soluble formulations versus amphotericin B in cancer patients with neutropenia meta_analysis pubmed_article
Quality: 73 2014 PMID: 25188673 DOI: 10.1002/14651858.CD000969.pub2
Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy rct pubmed_article
Quality: 72 2011 PMID: 22085343 DOI: 10.1056/NEJMoa1107579
Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders meta_analysis cochrane_review
Quality: 71 2013 PMID: 23897323 DOI: 10.1002/14651858.CD009733.pub2
Systematic review of CETP inhibitors for increasing high-density lipoprotein cholesterol: where do these agents stand in the approval process? systematic_review pubmed_article
Quality: 46 2015 PMID: 23567794 DOI: 10.1097/MJT.0b013e31828b8463
Anti-hypertensive drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies and clinical trials meta_analysis pubmed_article
Quality: 61 2011 PMID: 22071852 DOI: 10.1002/14651858.CD008535.pub2

View full evidence search →